PIXYL raises € 2.2 million to improve patient care by placing the most advanced neuroimaging AI technology in the hands of radiologists and clinicians.

Grenoble, April 29, 2021 – PIXYL, the award-winning French medtech specialized in delivering AI-powered clinical diagnostic support to radiologists and clinicians, announces a € 2.2 million round led by Elaia, and alongside new investors Holnest and Bpifrance. The company is also pleased to welcome an additional 32 radiologists and clinicians as business angels, including Groupe Clinique du Mail.

Pixyl is on a mission to make precision medicine the standard of care. This round will boost the European market launch of Pixyl.NeuroTM, the company’s first AI-powered, CE-marked, medical device. The funds will also support FDA regulatory clearance of the company’s products for our future U.S. expansion, as well as developing Pixyl’s product lines in predictive medicine and differential diagnostics.

Read the full press release